The 4100 Group
Overview
The 4100 Group is a growth equity and venture capital firm that operates as a patient capital vehicle focused on the healthcare and financial services sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Proclaim | Feb 2025 | VC Round | Co-investor |
| Clarapath | Nov 2021 | Series B | Co-investor |
| Vynca | Jan 2022 | Series C | Co-investor |
| Root Functional Medicine | Oct 2024 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The 4100 Group based?
The 4100 Group is headquartered in Lansing, Michigan, United States.
When was The 4100 Group founded?
The 4100 Group was founded in 2014.
How many portfolio companies does The 4100 Group have?
The 4100 Group has 5 portfolio companies in Caplight's dataset.
What are some companies in The 4100 Group's portfolio?
Portfolio companies visible on Caplight include Proclaim, Clarapath, Vynca, Root Functional Medicine.
What was The 4100 Group's most recent investment shown here?
The 4100 Group's most recent investment in this portfolio sample was in Proclaim in 2025.
What sectors does The 4100 Group focus on?
The 4100 Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software.
What company stages does The 4100 Group focus on?
The 4100 Group typically invests at the Mid stage.
What is The 4100 Group's AUM?
The 4100 Group's assets under management are estimated between $50.0M and $100.0M.